Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
Securities code: 600721 securities abbreviation: * ST Baihua Announcement No.: 2022-004 Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) shareholder
Announcement on progress of share reduction
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
1. Basic information of shareholding of major shareholders
Mr. Zhang Xiaoqing holds 31975 shares of the company (hereinafter referred to as “secondary stock”), accounting for 313.89% of the total share capital of the company through the issuance of “secondary stock”, which is held by Mr. Zhang Xiaoqing.
2. Progress of share reduction plan
(1) During the reduction period from December 28, 2021 to March 28, 2022, Mr. Zhang Xiaoqing plans to reduce his holdings of no more than 2.17% of the total share capital of Baihua village by means of centralized bidding and block trading through the Shanghai stock exchange system, that is, 8144122 shares (including 689500 shares I reduced through block trading on November 23, 2021). Among them: the number of shares reduced by centralized bidding transaction shall not exceed 1.00% of the total shares of Baihua village, i.e. 3751000 shares; The number of shares reduced by block trading shall not exceed 2.00% of the total shares of Baihua village, i.e. 7502000 shares. For details of the shareholders’ share reduction plan, the company posted it on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on December 4, 2021 And the announcement of Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) shareholders’ share reduction plan disclosed by Shanghai Securities News (Announcement No.: 2021-080).
(2) Mr. Zhang Xiaoqing did not reduce his shares during the period from December 28, 2021 to February 10, 2022 (more than half of the planned reduction time).
Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
1、 Basic information of the reducing entity before the reduction
Shareholder name shareholder identity shareholding quantity shareholding proportion current shareholding source
(shares)
Zhang Xiaoqing obtained 31371975 shares through non-public offering by more than 5% of non-largest shareholders
31886989 8.50% centralized bidding transaction: 515014 shares
The above reduction subjects have no concerted action.
2、 Implementation progress of share reduction plan
(I) major shareholders and directors, supervisors and senior executives disclose the implementation progress of the reduction plan for the following reasons:
The reduction time is more than half
Shareholder’s name number of holdings reduction during the period of holdings reduction method of holdings reduction price area total amount of holdings reduction current number of shares current holding (shares) proportion between (yuan / share) amount (yuan) (shares) proportion
Zhang Xiaoqing 0 0% 2021 / 12 / 28 centralized bidding transactions, large 0 – 0 0 31886989 8.50% ~ 2022 / 2 / 10 transactions
(II) whether the reduction is consistent with the plans and commitments previously disclosed by major shareholders
√ yes □ no
(III) within the time range of reduction, whether the listed company discloses major issues such as high transfer or planning merger and reorganization
matter
√ yes □ no
On June 15, 2021, the shareholders’ meeting of the company deliberated and approved the proposal on the company’s non-public offering of shares
For details, please refer to Xinjiang Baihua Village Co., Ltd. 2021 annual report disclosed by the company on June 16, 2021
Announcement on the resolution of the third extraordinary general meeting of shareholders (Announcement No.: 2021-053); February 8, 2022, public
The company has received the approval of non-public offering of shares (A shares, main board of Shanghai Stock Exchange, main board of Shenzhen Stock Exchange and B shares) of listed companies
For details of the acceptance notice, please refer to the “Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.” disclosed by the company on February 10, 2022
Announcement of the limited company on the acceptance of the application for non-public offering of shares by the CSRC (Announcement No.:
2022-003）。 The above announcements are on the website of Shanghai Stock Exchange (www.sse. Com. CN.) Shanghai Securities
Report disclosure.
Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721)
(IV) impact of this reduction on the company
Mr. Zhang Xiaoqing is not the controlling shareholder, actual controller and persons acting in concert of the company. The implementation of this reduction plan will not lead to the change of control of the listed company, nor will it have an impact on the continuous operation of the company. (V) other matters required by the exchange: none
3、 Relevant risk tips
(I) uncertainty in the implementation of the reduction plan
Mr. Zhang Xiaoqing will decide whether to implement the share reduction plan according to the market conditions, the company’s share price and other conditions, and there is uncertainty about whether to complete it on schedule.
(II) whether the implementation of the share reduction plan will lead to the risk of change in the control of the listed company □ yes √ no
(III) other risks
1. The reduction of shareholders’ shares in the listed company complies with the provisions of Several Provisions on the reduction of shares by shareholders, directors, supervisors and senior managers of listed companies (CSRC announcement [2017] No. 9) and the implementation rules for the reduction of shares by shareholders, directors, supervisors and senior managers of listed companies on Shanghai Stock Exchange and other relevant laws, regulations and normative documents. 2. The shareholder of this reduction does not belong to the controlling shareholder and actual controller of the listed company, and the implementation of this reduction plan will not lead to the change of the control right of the listed company.
3. Shareholders will strictly abide by the securities law of the people’s Republic of China, several provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies, the detailed rules for the implementation of the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies on Shanghai Stock exchange and other relevant laws, regulations and corresponding commitments, and fulfill the obligation of information disclosure in a timely manner.
It is hereby announced.
Xinjiang Bai Hua Cun Pharma Tech Co.Ltd(600721) board of directors February 11, 2022
